Zevra Therapeutics, Inc. ZVRA Europe — Segment long-lived assets
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Zevra Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NoncurrentAssets.
The official record: Zevra Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Zevra Therapeutics, Inc.'s europe — segment long-lived assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Zevra Therapeutics, Inc.'s europe — segment long-lived assets?
- Zevra Therapeutics, Inc. (ZVRA) reported europe — segment long-lived assets of $300K in Q1 2026.
- How has Zevra Therapeutics, Inc.'s europe — segment long-lived assets changed year-over-year?
- Zevra Therapeutics, Inc.'s europe — segment long-lived assets decreased by 25.0% year-over-year, from $400K to $300K.
- What does europe — segment long-lived assets mean?
- This metric represents the total book value of non-current, tangible, and intangible assets physically located or legally attributed to the European geographic segment. It reflects the capital intensity and infrastructure investment required to support commercial operations, clinical trials, or distribution networks within the European market. Investors use this to assess the company's regional asset footprint and the scale of its operational commitment to the territory.